Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters

Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae

(2011) Nan-Yao Lee et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy

(2010) C.-C. Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study

(2010) Stephen P. Hawser et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan

(2010) Po-Ren Hsueh et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints

(2008) G. Kahlmeter   CLINICAL MICROBIOLOGY AND INFECTION

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

(2008) Andrea Endimiani et al.   Expert Review of Anti-Infective Therapy

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES